1. Home
  2. GRAB vs ILMN Comparison

GRAB vs ILMN Comparison

Compare GRAB & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grab Holdings Limited

GRAB

Grab Holdings Limited

HOLD

Current Price

$5.20

Market Cap

21.5B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$128.82

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRAB
ILMN
Founded
2012
1998
Country
Singapore
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.5B
18.9B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
GRAB
ILMN
Price
$5.20
$128.82
Analyst Decision
Buy
Hold
Analyst Count
4
15
Target Price
$6.38
$114.93
AVG Volume (30 Days)
51.4M
1.5M
Earning Date
11-04-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
4.46
Revenue
$3,228,000,000.00
$4,288,000,000.00
Revenue This Year
$23.99
N/A
Revenue Next Year
$21.71
$2.08
P/E Ratio
$258.34
$28.91
Revenue Growth
20.18
N/A
52 Week Low
$3.36
$68.70
52 Week High
$6.62
$153.06

Technical Indicators

Market Signals
Indicator
GRAB
ILMN
Relative Strength Index (RSI) 41.13 66.70
Support Level $5.15 $124.27
Resistance Level $5.50 $129.72
Average True Range (ATR) 0.19 3.90
MACD 0.01 -0.41
Stochastic Oscillator 51.64 77.82

Price Performance

Historical Comparison
GRAB
ILMN

About GRAB Grab Holdings Limited

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: